Thursday, June 13, 2024

June 14, 2024 at 03:12AM TECARTUS

For the treatment of adult patients with relapsed or refractory (r/r) B-cell precursor acute lymphoblastic leukemia (B-ALL). For the treatment of adult patients with relapsed/refractory mantle cell lymphoma (r/r MCL).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/SXl7ajE

No comments:

Post a Comment